Insulin Glargine vs Comparators in Adults < 65 vs ≥ 65 Years of Age

被引:0
|
作者
Pandya, Naushira
Digenio, Andres
Patel, Meenakshi
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2295-PO
引用
收藏
页码:A610 / A610
页数:1
相关论文
共 50 条
  • [1] Pooled Analysis Reveals Greater Glycemic Control with Insulin Glargine vs Comparators in Adults Aged 65-74 and ≥75 Years
    Patel, Meenakshi
    Digenio, Andres
    Pandya, Naushira
    DIABETES, 2011, 60 : A617 - A617
  • [2] Efficacy and Goal Attainment with Insulin Glargine vs Comparators
    Banerji, Mary Ann
    Baron, Michelle
    Blonde, Lawrence
    DIABETES, 2010, 59 : A559 - A560
  • [3] Efficacy and goal attainment with insulin glargine vs comparators
    Banerji, M. A.
    Baron, M.
    Blonde, L.
    DIABETOLOGIA, 2010, 53
  • [4] Comparative Evaluation and Management of Dysphonia Between Adults <65 and ≥65 Years of Age
    Jacks, Amy
    Kavookjian, Hannah
    Kraft, Shannon
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2021, 165 (01) : 142 - 148
  • [5] Improved or comparable efficacy without increased hypoglycaemia with self- vs physician-led titration of insulin glargine 300 U/ml in age groups <65 or ≥65 years: TAKE CONTROL
    Strojek, K.
    Bigot, G.
    Bonnemaire, M.
    Delgado, E.
    Donicova, V.
    Kvapil, M.
    Papanas, N.
    Popescu, L.
    Ritzel, R.
    Schultes, B.
    Duvnjak, L. Smircic
    DIABETOLOGIA, 2018, 61 : S443 - S443
  • [6] Immune related adverse events in patients ≥65 years vs. <65 years with breast cancer treated with immunotherapy
    Vidula, Neelima
    Hutchinson, Jennifer
    McLaren, Abigail
    Ryan, Lianne
    Niemierko, Andrzej
    Bardia, Aditya
    CANCER RESEARCH, 2024, 84 (09)
  • [7] Similar Efficacy and Safety of LY2963016 Insulin Glargine and Insulin Glargine (Lantus®) in Patients with T2D in Age Groups (< 65 Yrs,=65 Yrs)
    Pollom, Robyn K.
    Costigan, Timothy
    Lacaya, Lyndon B.
    Ilag, Liza L.
    Hollander, Priscilla A.
    DIABETES, 2016, 65 : A249 - A249
  • [8] Comparison of Trends, Mortality, and Readmissions After Insertion of Left Ventricular Assist Devices in Patients <65 Years Vs ≥65 Years
    Rali, Aniket S.
    Ranka, Sagar
    Acharya, Prakash
    Buechler, Tyler
    Weidling, Robert
    Mastoris, Ioannis
    Taduru, Siva
    Abicht, Travis
    Haglund, Nicholas
    Sauer, Andrew J.
    Shah, Zubair
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 128 : 16 - 27
  • [9] Diclofenac Sodium Topical Gel 1% in Knee Osteoarthritis: Comparison of Safety and Efficacy in Patients Aged <65 years vs ≥65 years
    Baraf, H.
    Gloth, F.
    Clark, M.
    Gold, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 : S25 - S25
  • [10] Comparison of efficacy and safety assessment of Fluvastatin in patients <65 years versus ≥65 years of age
    Bruckert, E
    Verpilleux, MP
    Dejager, S
    Isaacsohn, J
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (08): : 1142 - 1148